Author response for 'The dose‐dependent efficacy of the glucose‐dependent insulinotropic polypeptide receptor antagonist, GIP (3‐30) NH 2 , on GIP actions in humans'

Autor:	Jens J. Holst, David S. Mathiesen, Bolette Hartmann, Mette M. Rosenkilde, Signe Stensen, Amalie R. Lanng, Lærke S. Gasbjerg, Emilie Johanning Bari, Mikkel Christensen, Filip K. Knop, Bjørn Hoe
Rok vydání:	2020
Předmět:	business.industry medicine.drug_class Dose dependence Medicine Glucose-dependent insulinotropic polypeptide Pharmacology business Receptor antagonist
DOI:	10.1111/dom.14186/v2/response1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f7e9421e4042306d1b04e1bc37916cff https://doi.org/10.1111/dom.14186/v2/response1 Zobrazit plný text záznamu